secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2023-03-15T23:59:59+00:00
Accession:  0000719135-23-000012
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical sells headquarters for $7.65M in sale-leaseback; expects $6.7M net proceeds
--------------------------------------------------------------------------------

- Sale price $7,650,000 for Clearwater, FL facility; net proceeds estimated at ~$6.7M after taxes and fees.
- Leaseback for 10-year initial term at $619,500 annual rent, escalating 4% per year; triple-net lease.
- Proceeds will be used to strengthen balance sheet and provide working capital.
- Purchaser paid $400,000 earnest money; due diligence period of 30 days from March 14, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000071913523000012/0000719135-23-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000071913523000012/apyx-20230314.htm
  HTML page:      https://secwatch.observer/filing/0000719135-23-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer